Tierarztl Prax Ausg K Kleintiere Heimtiere 2015; 43(05): 351-357
DOI: 10.15654/TPK-150354
Für Studium und Praxis
Schattauer GmbH

Diagnose der kaninen Parvovirus-Infektion

Diagnostic tools for canine parvovirus infection
A. L. Proksch
1   Medizinische Kleintierklinik der Ludwig-Maximilians-Universität München
,
K. Hartmann
1   Medizinische Kleintierklinik der Ludwig-Maximilians-Universität München
› Author Affiliations
Further Information

Publication History

Eingegangen: 22 May 2015

Akzeptiert nach Revision: 21 July 2015

Publication Date:
08 January 2018 (online)

Zusammenfassung

Die kanine Parvovirus-Infektion stellt die weltweit häufigste Viruserkrankung beim Hund dar und weist noch immer eine sehr hohe Mortalitätsrate auf. Sie betrifft vor allem Welpen, wenn deren Titer an maternalen Antikörpern abgesunken ist und sich impfinduzierte Antikörper noch nicht entwickelt haben. Eine schnelle und sichere Diagnose ist aus zwei Gründen essenziell, einerseits, um erkrankte Welpen schnell zu erkennen und sie einer intensiven Therapie zu unterziehen, andererseits, um Ausscheider zu identifizieren und eine Verbreitung des Virus zu vermeiden. Zur Diagnosestellung gibt es viele verschiedene Möglichkeiten. Während sich der Nachweis von Antikörpern gegen kanine Parvoviren für die Diagnose nicht eignet, ist der Nachweis der Viren oder ihrer Bestandteile (Antigen, DNA) beweisend. Für diesen direkten Erregernachweis können verschiedene Tests aus kommerziellen Labors wie auch auf ELISA basierende praxistaugliche Schnelltests verwendet werden. Letztgenannte verfügen über eine durchweg exzellente Spezifität, doch liegt die Anzahl falsch negativer Testergebnisse in der Regel sehr hoch, woraus sich Fehldiagnosen ergeben können. Die Polymerasekettenreaktion ist eine sehr sensitive und spezifische Nachweismethode. Sie bietet den weiteren Vorteil, dass durch eine sich anschließende Sequenzierung eine Differenzierung zwischen Impf- und Feldstämmen vorgenommen werden kann.

Summary

Canine parvovirus (CPV) infection is one of the most important and common infectious diseases in dogs, in particular affecting young puppies when maternal antibodies have waned and vaccine-induced antibodies have not yet developed. The mortality rate remains high. Therefore, a rapid and safe diagnostic tool is essential to diagnose the disease to 1) provide intensive care treatment and 2) to identify virusshedding animals and thus prevent virus spread. Whilst the detection of antibodies against CPV is considered unsuitable to diagnose the disease, there are several different methods to directly detect complete virus, virus antigen or DNA. Additionally, to test in commercial laboratories, rapid in-house tests based on ELISA are available worldwide. The specificity of the ELISA rapid in-house tests is reported to be excellent. However, results on sensitivity vary and high numbers of false-negative results are commonly reported, which potentially leads to misdiagnosis. Polymerase chain reaction (PCR) is a very sensitive and specific diagnostic tool. It also provides the opportunity to differentiate vaccine strains from natural infection when sequencing is performed after PCR.

 
  • Literatur

  • 1 Büttner M. Direkter Virusnachweis. In: Medizinische Mikrobiologie, Infektions- und Seuchenlehre. Mayr A. Hrsg. Stuttgart: Enke; 2002: 130-131.
  • 2 Carman PS, Povey RC. Pathogenesis of canine parvovirus-2 in dogs: haematology, serology and virus recovery. Res Vet Sci 1985; 38: 134-140.
  • 3 Carmichael LE, Joubert JC, Pollock RV. Hemagglutination by canine parvovirus: serologic studies and diagnostic applications. Am J Vet Res 1980; 41: 784-791.
  • 4 Carmichael LE, Joubert JC, Pollock RV. A modified live canine parvovirus vaccine. II. Immune response. Cornell Vet 1983; 73: 13-29.
  • 5 Cavalli A, Martella V, Desario C, Camero M, Bellacicco AL, De Palo P, Decaro N, Elia G, Buonavoglia C. Evaluation of the antigenic relationships among canine parvovirus type 2 variants. Clin Vaccine Immunol 2008; 15: 534-539.
  • 6 Decaro N, Desario C, Campolo M, Elia G, Martella V, Ricci D, Lorusso E, Buonavoglia C. Clinical and virological findings in pups naturally infected by canine parvovirus type 2 Glu-426 mutant. J Vet Diagn Invest 2005; 17: 133-138.
  • 7 Decaro N, Elia G, Martella V, Desario C, Campolo M, Trani LD, Tarsitano E, Tempesta M, Buonavoglia C. A real-time PCR assay for rapid detection and quantitation of canine parvovirus type 2 in the feces of dogs. Vet Microbiol 2005; 105: 19-28.
  • 8 Decaro N, Elia G, Martella V, Campolo M, Desario C, Camero M, Cirone F, Lorusso E, Lucente MS, Narcisi D, Scalia P, Buonavoglia C. Characterisation of the canine parvovirus type 2 variants using minor groove binder probe technology. J Virol Methods 2006; 133: 92-99.
  • 9 Decaro N, Martella V, Elia G, Desario C, Campolo M, Buonavoglia D, Bellacicco AL, Tempesta M, Buonavoglia C. Diagnostic tools based on minor groove binder probe technology for rapid identification of vaccinal and field strains of canine parvovirus type 2b. J Virol Methods 2006; 138: 10-16.
  • 10 Decaro N, Elia G, Desario C, Roperto S, Martella V, Campolo M, Lorusso A, Cavalli A, Buonavoglia C. A minor groove binder probe real-time PCR assay for discrimination between type 2-based vaccines and field strains of canine parvovirus. J Virol Methods 2006; 136: 65-70.
  • 11 Decaro N, Desario C, Elia G, Campolo M, Lorusso A, Mari V, Martella V, Buonavoglia C. Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: a clinical and laboratory diagnostic dilemma. Vaccine 2007; 25: 1161-1166.
  • 12 Decaro N, Desario C, Beall MJ, Cavalli A, Campolo M, Dimarco AA, Amorisco F, Colaianni ML, Buonavoglia C. Detection of canine parvovirus type 2c by a commercially available in-house rapid test. Vet J 2010; 184: 373-375.
  • 13 Decaro N, Buonavoglia C. Canine parvovirus – a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 2012; 155: 1-12.
  • 14 Desario C, Decaro N, Campolo M, Cavalli A, Cirone F, Elia G, Martella V, Lorusso E, Camero M, Buonavoglia C. Canine parvovirus infection: which diagnostic test for virus?. J Virol Methods 2005; 126: 179-185.
  • 15 Drane DP, Hamilton RC, Cox JC. Evaluation of a novel diagnostic test for canine parvovirus. Vet Microbiol 1994; 41: 293-302.
  • 16 Esfandiari J, Klingeborn B. A comparative study of a new rapid and onestep test for the detection of parvovirus in faeces from dogs, cats and mink. J Vet Med B Infect Dis Vet Public Health 2000; 47: 145-153.
  • 17 Goddard A, Leisewitz AL. Canine parvovirus. Vet Clin North Am Small Anim Pract 2010; 40: 1041-1053.
  • 18 Gray LK, Crawford PC, Levy JK, Dubovi EJ. Comparison of two assays for detection of antibodies against canine parvovirus and canine distemper virus in dogs admitted to a Florida animal shelter. J Am Vet Med Assoc 2012; 240: 1084-1087.
  • 19 Greene CE, Decaro N. Canine viral enteritis. In: Infectious Disease of the Dog and Cat. Greene CE. ed. Philadelphia: Elsevier Saunders; 2012: 67-75.
  • 20 Hammond MM, Timoney PJ. An electron microscopic study of viruses associated with canine gastroenteritis. Cornell Vet 1983; 73: 82-97.
  • 21 Iris K, Leontides LS, Mylonakis ME, Adamama-Moraitou K, Rallis T, Koutinas AF. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection. Res Vet Sci 2010; 89: 174-178.
  • 22 Kuffer M, Schunck B, Hartmann K, Kraft W. [Rapid enzymatic test for diagnosis of parvovirus infections in dogs]. Tierärztl Prax 1995; 23: 415-417.
  • 23 Kumar M, Nandi S, Chidri S. Development of a polyclonal antibody-based AC-ELISA and its comparison with PCR for diagnosis of canine parvovirus infection. Virol Sin 2010; 25: 352-360.
  • 24 Lappin MR. Laboratory diagnosis of infectious disease. In: Textbook of Veterinary Internal Medicine. Ettinger SJ, Feldman EC. eds. Philadelphia: Saunders Elsevier; 2010: 847-853.
  • 25 Litster A, Nichols J, Volpe A. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters. Vet Microbiol 2012; 157: 86-90.
  • 26 Litster AL, Pressler B, Volpe A, Dubovi E. Accuracy of a point-of-care ELISA test kit for predicting the presence of protective canine parvovirus and canine distemper virus antibody concentrations in dogs. Vet J 2012; 193: 363-366.
  • 27 Luff PR, Wood GW, Hebert CN, Thornton DH. Canine parvovirus serology: a collaborative assay. Vet Rec 1987; 120: 270-273.
  • 28 Markovich JE, Stucker KM, Carr AH, Harbison CE, Scarlett JM, Parrish CR. Effects of canine parvovirus strain variations on diagnostic test results and clinical management of enteritis in dogs. J Am Vet Med Assoc 2012; 241: 66-72.
  • 29 Marulappa SY, Kapil S. Simple tests for rapid detection of canine parvovirus antigen and canine parvovirus-specific antibodies. Clin Vaccine Immunol 2009; 16: 127-131.
  • 30 Mathys A, Mueller R, Pedersen NC, Theilen GH. Hemagglutination with formalin-fixed erythrocytes for detection of canine parvovirus. Am J Vet Res 1983; 44: 150-151.
  • 31 Mochizuki M, San Gabriel MC, Nakatani H, Yoshida M, Harasawa R. Comparison of polymerase chain reaction with virus isolation and haemagglutination assays for the detection of canine parvoviruses in faecal specimens. Res Vet Sci 1993; 55: 60-63.
  • 32 Müller E. Klinische Mikrobiologie. In: Klinische Labordiagnostik. Moritz A. Hrsg. Stuttgart: Schattauer; 2014: 595-628.
  • 33 Neuerer FF, Horlacher K, Truyen U, Hartmann K. Comparison of different in-house test systems to detect parvovirus in faeces of cats. J Feline Med Surg 2008; 10: 247-251.
  • 34 Oh JS, Ha GW, Cho YS, Kim MJ, An DJ, Hwang KK, Lim YK, Park BK, Kang B, Song DS. One-step immunochromatography assay kit for detecting antibodies to canine parvovirus. Clin Vaccine Immunol 2006; 13: 520-524.
  • 35 Parrish CR, O’Connell PH, Evermann JF, Carmichael LE. Natural variation of canine parvovirus. Science 1985; 230: 1046-1048.
  • 36 Pollock RV, Carmichael LE. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 1982; 180: 37-42.
  • 37 Proksch AL, Unterer S, Speck S, Truyen U, Hartmann K. Influence of clinical and laboratory variables on faecal antigen ELISA results in dogs with canine parvovirus infection. Vet J 2015; 204 (03) 304-308.
  • 38 Puentes R, Eliopulos N, Perez R, Franco G, Sosa K, Bianchi P, Furtado A, Hubner SO, Esteves PA. Isolation and characterization of canine parvovirus type 2C (CPV-2C) from symptomatic puppies. Braz J Microbiol 2012; 43: 1005-1009.
  • 39 Rimmelzwaan GF, Juntti N, Klingeborn B, Groen J, UytdeHaag FG, Osterhaus AD. Evaluation of enzyme-linked immunosorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections. Vet Q 1990; 12: 14-20.
  • 40 Rimmelzwaan GF, Groen J, Egberink H, Borst GH, UytdeHaag FG, Osterhaus AD. The use of enzyme-linked immunosorbent assay systems for serology and antigen detection in parvovirus, coronavirus and rotavirus infections in dogs in The Netherlands. Vet Microbiol 1991; 26: 25-40.
  • 41 Schmitz S, Coenen C, Konig M, Thiel HJ, Neiger R. Comparison of three rapid commercial canine parvovirus antigen detection tests with electron microscopy and polymerase chain reaction. J Vet Diagn Invest 2009; 21: 344-345.
  • 42 Schunck B, Kraft W, Truyen U. A simple touch-down polymerase chain reaction for the detection of canine parvovirus and feline panleukopenia virus in feces. J Virol Methods 1995; 55: 427-433.
  • 43 Senda M, Hirayama N, Yamamoto H, Kurata K. An improved hemagglutination test for study of canine parvovirus. Vet Microbiol 1986; 12: 1-6.
  • 44 Senda M, Hirayama N, Itoh O, Yamamoto H. Canine parvovirus: strain difference in haemagglutination activity and antigenicity. J Gen Virol 1988; 69 (Pt 2): 349-354.
  • 45 Streck AF, Ruster D, Truyen U, Homeier T. An updated TaqMan real-time PCR for canine and feline parvoviruses. J Virol Methods 2013; 193: 6-8.
  • 46 Studdert MJ, Oda C, Riegl CA, Roston RP. Aspects of the diagnosis, pathogenesis and epidemiology of canine parvovirus. Aust Vet J 1983; 60: 197-200.
  • 47 Teramoto YA, Mildbrand MM, Carlson J, Collins JK, Winston S. Comparison of enzyme-linked immunosorbent assay, DNA hybridization, hemagglutination, and electron microscopy for detection of canine parvovirus infections. J Clin Microbiol 1984; 20: 373-378.
  • 48 Tizard I, Ni Y. Use of serologic testing to assess immune status of companion animals. J Am Vet Med Assoc 1998; 213: 54-60.
  • 49 Truyen U. Evolution of canine parvovirus – a need for new vaccines?. Vet Microbiol 2006; 117: 9-13.
  • 50 Twark L, Dodds WJ. Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs. J Am Vet Med Assoc 2000; 217: 1021-1024.
  • 51 Waner T, Naveh A, Wudovsky I, Carmichael LE. Assessment of maternal antibody decay and response to canine parvovirus vaccination using a clinic-based enzyme-linked immunosorbent assay. J Vet Diagn Invest 1996; 08: 427-432.
  • 52 Waner T, Mazar S, Nachmias E, Keren-Kornblatt E, Harrus S. Evaluation of a dot ELISA kit for measuring immunoglobulin M antibodies to canine parvovirus and distemper virus. Vet Rec 2003; 152: 588-591.